Express Pharma

CSIR and Mylan in partnership to develop therapeutic options for COVID–19 management

The application for the clinical trials has been submitted to DCGI for regulatory approval

0 922

The Council of Scientific & Industrial Research (CSIR) and Mylan Laboratories announced a partnership under which CSIR’s constituent laboratory Indian Institute of Chemical Technology (CSIR-IICT) and Mylan will collaborate to identify potential therapies for COVID-19.

A series of clinical trials will be conducted towards new and innovative solutions to manage COVID-19 pandemic in India as part of this collaboration. The first of the clinical trial to be rolled out is a multiple arm phase 3 study that will be conducted in adult patients with mild to moderate COVID -19 at risk of complications.

The application for the clinical trials has been submitted to the Drugs Controller General of India (DCGI) for regulatory approval.

CSIR has appointed Dr Ram Vishwakarma, Honorary Advisor to